Clear Harbor Asset Management’s Pacific Biosciences PACB Stock Holding History

Clear Harbor Asset Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.2K	Sell	29,900 -14,230	-32%	-$20.7K	﹤0.01%	444
2026 Q1	$58.3K	Sell	44,130 -14,580	-25%	-$26.1K	﹤0.01%	438
2025 Q4	$110K	Sell	58,710 -66,584	-53%	-$128K	0.01%	426
2025 Q3	$160K	Buy	125,294 +2,400	+2%	+$3.25K	0.01%	400
2025 Q2	$152K	Sell	122,894 -290	-0.2%	-$335	0.01%	391
2025 Q1	$145K	Buy	123,184 +9,298	+8%	+$14.3K	0.01%	382
2024 Q4	$208K	Sell	113,886 -6,000	-5%	-$11.7K	0.02%	349
2024 Q3	$204K	Sell	119,886 -50	-0%	-$82	0.02%	336
2024 Q2	$164K	Buy	119,936 +5,000	+4%	+$10.1K	0.01%	337
2024 Q1	$431K	Buy	114,936 +50,886	+79%	+$298K	0.04%	240
2023 Q4	$628K	Buy	64,050 +7,400	+13%	+$60.5K	0.06%	194
2023 Q3	$473K	Sell	56,650 -600	-1%	-$6.86K	0.05%	212
2023 Q2	$761K	Buy	57,250 +36	+0.1%	+$438	0.07%	171
2023 Q1	$663K	Buy	57,214 +3,662	+7%	+$36.4K	0.07%	199
2022 Q4	$438K	Buy	53,552 +3,802	+8%	+$32.8K	0.05%	224
2022 Q3	$289K	Hold	49,750	–	–	0.04%	265
2022 Q2	$220K	Buy	+49,750	New	+$302K	0.03%	314
2020 Q4	–	Sell	-5,500	Closed	-$54.3K	–	610
2020 Q3	$54.3K	Buy	+5,500	New	+$31.7K	0.01%	384

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Clear Harbor Asset Management's PACB Position: Q2 2026 in Review

Clear Harbor Asset Management reduced its Pacific Biosciences (PACB) stake by 32% in Q2 2026, selling an estimated $20.7K and leaving 29,900 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #444.

Clear Harbor Asset Management first reported a position in PACB in Q3 2020 and has held it in 18 quarters since. The position peaked at $761K in Q2 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Clear Harbor Asset Management held 29,900 shares of Pacific Biosciences worth $50.2K as of Q2 2026.
Clear Harbor Asset Management sold 14,230 Pacific Biosciences shares in Q2 2026, an estimated $20.7K.
Pacific Biosciences made up ﹤0.01% of Clear Harbor Asset Management's portfolio in Q2 2026, its #444 holding.
Clear Harbor Asset Management first reported a position in Pacific Biosciences in Q3 2020 and has held it in 18 quarters since.
Clear Harbor Asset Management's Pacific Biosciences position peaked at $761K in Q2 2023.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.